Neurodevelopmental Disorders: Studying the Clinical Impact of Genomic Sequencing

Title

Neurodevelopmental Disorders: Studying the Clinical Impact of Genomic Sequencing

Files

Download Transcript, Episode 49 (75 KB)

Loading...

Media is loading
 

Document Type

Podcast

Hosts

Michael Smith

Featured Speaker

Sarah E. Soden, MD

Length of Episode

8:53

Description

Neurodevelopmental disorders, such as intellectual disability, Tourette syndrome, autism and neuromuscular diseases affect more than 10 percent of children.

Recent advances in genomic medicine are unraveling the etiology of these disorders and providing answers to more patients and families.

These discoveries, along with advances in pharmacogenomics are the foundation of precision medicine.

This topic is important to many and is an area of focus regarding active studies being conducted within the Genome Center.

Hear from Sarah Soden, MD, on GSEND (Genomic Sequencing for the Etiology of Neurodevelopmental Disorders) a prospective study designed to determine whether genomic sequencing early in a child’s diagnostic evaluation improves diagnoses and transforms outcomes.

Click here to stream the podcast episode.

Publication Date

5-2-2016

Neurodevelopmental Disorders: Studying the Clinical Impact of Genomic Sequencing

Share

COinS